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1336produce a complete recovery from a potentially life-threatening
situation (3,4).
The low reporting rate of complete AV block in patients with
rheumatic diseases might be due to a low incidence of this phe-
nomenon (3). It may also be due to the lack of a more involved
search for autoimmune causes in patients with unexplained AV
block, including patients with no history or suspicion of autoim-
mune disease.
Study limitations include those of all retrospective single-center
studies and the lack of information regarding deceased patients
and from patients lost to follow-up. In addition, the capacity,
techniques, and accuracy of diagnosing structural heart disease may
have changed between 1987 and 2012. We excluded patients older
than 50 years in an effort to avoid cases of idiopathic senile
degeneration of the conduction system.
In summary, our data, gathered from a 25-year retrospective
pacemaker series, suggest that autoimmunity should be excluded
in adults with complete AV block. Performing a screening for
ANA and anti-Ro/SSA antibodies could be a useful tool in the
characterization of adult patients with AV block of unknown
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Pattern in Patients With
ST-Segment Elevation
Myocardial Infarction
Caused by Plaque
Erosion Versus Plaque
Rupture After Successful
Fibrinolysis
An Optical Coherence Tomography StudyTo the Editor: Previous studies have shown that plaque rupture and
plaque erosion are the 2 most common underlying mechanisms for
sudden cardiac death and acute coronary syndrome (1,2). In a
rupture, the exposure of the necrotic core to the circulation is the
primary thrombogenic substrate, whereas in erosion, proteoglycan
and smooth muscle cells are believed to be the primary stimuli for
thrombosis (1,3). Because it is known that the necrotic core is 6
times more thrombogenic than all other plaque components (4), it
is possible that thrombus caused by erosion may respond better to
ﬁbrinolytic therapy compared with those caused by rupture.
In this study, we compared the residual thrombus burden, dis-
tribution, and characteristics of patients with ST-segment elevation
myocardial infarction (STEMI) caused by erosion versus rupture
after successful reperfusion with ﬁbrinolysis using optical coherence
tomography (OCT).
Twenty-nine patients with STEMI who were treated with
tenecteplase were enrolled in this study. Between 24 and 48 h after
successful ﬁbrinolysis, patients underwent nonocclusive time-
domain OCT imaging of culprit lesions before any intervention.
All patients provided written informed consent before the start of
the study. The study protocol was approved by the Institutional
Ethics Committee of Athens Medical School.
OCT images were analyzed at 0.5-mm intervals for a 10-mm
segment, including 5-mm distal and 5-mm proximal to the site of
minimal lumen area (MLA). Thrombus was deﬁned as a ﬂoating
or protruding mass into the lumen with a dimension 250 mm
andwas categorized as either erythrocyte-rich (red) thrombus, deﬁned
by high backscattering and high attenuation, or platelet-rich (white)
thrombus, deﬁned by homogeneous backscattering with low attenu-
ation. Residual thrombus burden was evaluated by calculating the
thrombus score based on a semiquantitative assessment of thrombus
by summing the number of involved quadrants containing thrombus
on cross-sectional OCT images (5). Plaque rupture was identiﬁed by
the presence of ﬁbrous cap discontinuity with a clear cavity formed
inside the plaque. Plaque erosion was deﬁned as the presence of
intracoronary thrombus attached to the luminal surface with no
detectable signs of ﬁbrous cap rupture (Fig. 1A) (2). The relationship
between the location of rupture site andMLA site was also evaluated.
All statistical analyses were performed by an independent statis-
tician. Categorical variables are presented as counts and proportions,
Figure 1 Residual Thrombus After Fibrinolysis in Plaque Rupture Versus Plaque Erosion
(A) Plaque erosion with white thrombus (white arrows) attached to the luminal surface without evidence of ﬁbrous cap rupture. (B) Residual thrombus burden. Plaque rupture
compared with erosion had a signiﬁcantly greater residual thrombus burden. (C) In plaque rupture, the core of thrombus was rich in platelets. Proximal and distal segments were
ﬁlled with red thrombus. (D) Plaque erosion showed primarily white thrombus.
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1337and comparisons of thrombus incidence rates among locations were
performed based on multiple segments per patient by using GEE.
Continuous variables are presented as mean  SD and were
examined using the Student t test between the 2 groups. All sta-
tistical analyses were performed with IBM SPSS software version
19.0 (SPSS Inc., Chicago, Illinois).
Of the 29 patients, 6 were excluded due to poor image quality.
The mean age was 60.5  10.9 years in the rupture group and
58.0  11.9 years in the erosion group (p ¼ 0.65). The time delay
from symptom onset to ﬁbrinolysis (3.5  1.2 h [rupture] vs. 3.3
 0.9 h [erosion]; p ¼ 0.78) and from ﬁbrinolysis to catheterization
(31.2  8 h [rupture] vs. 33.1  7.6 h [erosion]; p ¼ 0.60) was
similar between the 2 groups.
Of 23 culprit lesions, 11 (47.8%) were diagnosed as plaque
rupture and 8 (34.8%) as plaque erosion. Four cases (17.4%) did
not meet the criteria for either category. Rupture sites were located
proximal to the MLA in 72.7%, at the MLA site in 18.2%, and
distal to the MLA in 9.1% of patients. Thrombus burden was
signiﬁcantly greater for rupture than for erosion (14.2  9.4 vs. 6.5
 4.5; p ¼ 0.049) (Fig. 1B).
In a rupture, white thrombus was primarily located at the MLA
sites (22.5%) compared to proximal (1.6%, p ¼ 0.007) and distal
(5.5%, p¼ 0.002) segmentwhereas red thrombusdid not show such a
marked difference (17.3% [proximal], 25.5% [MLA], and 31.9%
[distal],NS) (Fig. 1C). In erosion, onlywhite thrombuswas detected,whichwas primarily located at theMLA sites except in 1 patient with
minimal red thrombus in the proximal segment (Fig. 1D).
Our study demonstrates that residual thrombus burden 1 day after
ﬁbrinolysis was greater in a rupture compared with erosion in
patients with successful ﬁbrinolysis for STEMI. In a rupture, the
core of the thrombus primarily consisted of platelets, and red
thrombus was evenly distributed over the entire culprit lesion length.
In erosion, white thrombus was the predominant type at the culprit
site, and red thrombus was sparse. These ﬁndings suggest that
underlying plaque morphology in STEMI plays an important role
in thrombosis and subsequent response to thrombolytic therapy.
Some limitations exist in our study. First, the ﬁndings of the
present study were based on a small cohort of patients who had
successful ﬁbrinolysis. Second, OCT was performed 1 day after
ﬁbrinolysis. It is possible that thrombus might have been reduced or
resolved with continuous antithrombotic therapy, and residual
thrombus could have been organized. However, it is unlikely that
plaque morphology would have changed signiﬁcantly during that
period. Third, it is possible that small ruptures shadowed by
overlying red thrombus were not detected, and therefore the
diagnosis of erosion might have been overestimated.
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Things Are Not Always
What They Seem
Shishehbor et al. (1) performed an analysis of outcomes after
3 strategies for treating cardiac surgery patients with concurrent
carotid disease. They concluded (in a cohort of predominantly
asymptomatic patients with unilateral carotid disease) that staged
carotid artery stenting (CAS) and open-heart surgery (OHS) and
combined carotid endarterectomy (CEA) and OHS have similar
procedural risks but that outcomes favored staged CAS-OHS
after the ﬁrst year. In a subsequent interview, Dr. Shishehbor
urged readers to “remember the whole point of doing this is to
prevent stroke” (2). Shishehbor et al. (1) are absolutely correct in their
statement, and it is therefore inexplicable that not once in the
group’s report did the investigators mention that there is a fourth
treatment strategy, namely, to perform no prophylactic carotid inter-
vention at all.
The Shishehbor et al. (1) study was based on 3 assumptions:
ﬁrst, that carotid disease is an important cause of stroke after
coronary artery bypass grafting (CABG); second, that patients with
asymptomatic carotid stenoses are at excess risk for stroke; and
third, that prophylactic CEA or CAS can reduce this risk. Un-
fortunately, at least 2 of these assumptions do not stand up to
scrutiny. First, 3 large natural-history studies (including 23,557
patients) showed that 95% of all post-CABG strokes cannot be
attributed to carotid disease (3–5). Second, an extensive systematic
review and meta-analysis showed that patients with unilateral,
asymptomatic carotid stenoses face a very small risk for ipsilateral
stroke (6). In addition, another systematic review showed that the
risk for stroke ipsilateral to the nonoperated severe carotid stenosis
in patients with bilateral severe carotid disease undergoing syn-
chronous CEA plus CABG was extremely low (7). If carotid
disease were responsible for a signiﬁcant proportion of post-CABG
strokes, the opposite should have been found.
The rationale underpinning prophylactic CEA or CAS is that it
reduces the risk for stroke after CABG. The prevention of late
stroke is not relevant to this debate. Accordingly, no one should
criticize anyone offering synchronous CEA and CABG or staged
CAS and CABG in patients reporting histories of transient
ischemic attack or stroke. It has long been accepted that these
patients really are at higher risk for post-CABG stroke. However,
the evidence justifying prophylactic CEA or CAS before CABG
